Special Post

Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the…

(Bloomberg) — For more than a year, Nvidia Corp. has been the go-to trade for investors seeking exposure…

In today’s video, I discuss both the bullish and bearish points for Super Micro Computer (NASDAQ: SMCI). Check…

Nvidia shares have fallen back after pushing past $700. The chip maker’s rally looks to be being hit…

(Reuters) -Shares of New York Community Bancorp dived another 9% on Tuesday, extending a sell-off since the lender…

An analyst at Seaport Research pulled his Buy rating on shares, saying he would remain on the sidelines…

Palantir (PLTR) stock soared more than 25% Tuesday morning as investors cheered the defense software maker’s latest artificial…

Excitement over the sales potential of Lilly’s new obesity medicine has sent shares soaring this year.

(Reuters) -Eli Lilly forecast 2024 profit above Wall Street expectations on Tuesday on soaring demand for its weight-loss…

Alibaba and other Chinese names surged on Tuesday, bouncing back after a brutal selloff in recent days as…

Nvidia shares break past $700 a share in premarket trading. The chip maker is striking more deals with…

Shares of ailing fintech firm PayPal (NASDAQ:PYPL) failed to impress (or “shock the world”) when it revealed its…